These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 28950862)

  • 1. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
    Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
    BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.
    Singh BK; Michael E
    Parasit Vectors; 2015 Oct; 8():522. PubMed ID: 26490350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
    Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
    BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale.
    Touloupou P; Fronterre C; Cano J; Prada JM; Smith M; Kontoroupis P; Brown P; Rivera RC; de Vlas SJ; Gunawardena S; Irvine MA; Njenga SM; Reimer L; Seife F; Sharma S; Michael E; Stolk WA; Pulan R; Spencer SEF; Hollingsworth TD
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S108-S116. PubMed ID: 38662704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of lymphatic filariasis as a public health problem in Malawi.
    Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.
    Silumbwe A; Zulu JM; Halwindi H; Jacobs C; Zgambo J; Dambe R; Chola M; Chongwe G; Michelo C
    BMC Public Health; 2017 May; 17(1):484. PubMed ID: 28532397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.
    Moraga P; Cano J; Baggaley RF; Gyapong JO; Njenga SM; Nikolay B; Davies E; Rebollo MP; Pullan RL; Bockarie MJ; Hollingsworth TD; Gambhir M; Brooker SJ
    Parasit Vectors; 2015 Oct; 8():560. PubMed ID: 26496983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.
    Michael E; Sharma S; Smith ME; Touloupou P; Giardina F; Prada JM; Stolk WA; Hollingsworth D; de Vlas SJ
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006674. PubMed ID: 30296266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulating a Transmission Assessment Survey: An evaluation of current methods used in determining the elimination of the neglected tropical disease, Lymphatic Filariasis.
    Weiss PS; Michael E; Richards FO
    Int J Infect Dis; 2021 Jan; 102():422-428. PubMed ID: 33130207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic filariasis in Papua New Guinea: prospects for elimination.
    Bockarie MJ; Kazura JW
    Med Microbiol Immunol; 2003 Feb; 192(1):9-14. PubMed ID: 12592558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis.
    Harris JR; Wiegand RE
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005610. PubMed ID: 28542274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.
    Gambhir M; Michael E
    PLoS One; 2008 Aug; 3(8):e2874. PubMed ID: 18716676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.
    Smith ME; Singh BK; Irvine MA; Stolk WA; Subramanian S; Hollingsworth TD; Michael E
    Epidemics; 2017 Mar; 18():16-28. PubMed ID: 28279452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating elimination thresholds and stopping criteria for interventions against the vector-borne macroparasitic disease, lymphatic filariasis, using mathematical modelling.
    Sharma S; Smith ME; Bilal S; Michael E
    Commun Biol; 2023 Feb; 6(1):225. PubMed ID: 36849730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Spatial Statistics in the Control and Elimination of Neglected Tropical Diseases in Sub-Saharan Africa: A Focus on Human African Trypanosomiasis, Schistosomiasis and Lymphatic Filariasis.
    Stanton MC
    Adv Parasitol; 2017; 97():187-241. PubMed ID: 28325371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.
    Sharma S; Smith ME; Reimer J; O'Brien DB; Brissau JM; Donahue MC; Carter CE; Michael E
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007094. PubMed ID: 31260444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt.
    Smith ME; Singh BK; Michael E
    Sci Rep; 2017 Aug; 7(1):7386. PubMed ID: 28785097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.